Cardiovascular system | |||||
---|---|---|---|---|---|
Cardiovascular system / Patent ductus arteriosus | |||||
dinoprostone | Hospital only | ||||
Vaginal device | |||||
Propess (Ferring Pharmaceuticals Ltd) | Hospital only | ||||
Vaginal gel | |||||
Prostin E2 (Pfizer Ltd) | Hospital only | ||||
Cardiovascular system / Arrhythmias | |||||
acebutolol | Not approved for prescribing | ||||
adenosine | Hospital only | ||||
Solution for injection | |||||
Adenosine (Non-proprietary) | Hospital only | ||||
Adenocor (Sanofi) | Hospital only | ||||
Solution for infusion | |||||
Adenosine (Non-proprietary) | Hospital only | ||||
Adenoscan (Sanofi) | Hospital only | ||||
amiodarone hydrochloride | Specialist knowledge/initiation | ||||
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
Solution for injection | |||||
Amiodarone hydrochloride (Non-proprietary) | Hospital only | ||||
Cordarone X (Sanofi) | Hospital only | ||||
atenolol | Joint formulary choice | ||||
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
Oral solution | |||||
Atenolol (Non-proprietary) | Joint formulary choice | ||||
Solution for injection | |||||
Tenormin (Atnahs Pharma UK Ltd) | Hospital only | ||||
atropine sulfate | Hospital only | ||||
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
Solution for injection | |||||
Atropine sulfate (Non-proprietary) | Hospital only | ||||
digoxin | Specialist knowledge/initiation | ||||
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
Solution for injection | |||||
Digoxin (Non-proprietary) | Hospital only | ||||
disopyramide | Hospital only | ||||
Modified-release tablet | |||||
Rythmodan Retard (Neon Healthcare Ltd) | Hospital only | ||||
dronedarone | Hospital only |
NICE TA197 |
|||
esmolol hydrochloride | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Solution for injection | |||||
Esmolol hydrochloride (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Brevibloc (Baxter Healthcare Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Solution for infusion | |||||
Brevibloc (Baxter Healthcare Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
flecainide acetate | Specialist knowledge/initiation | ||||
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
lidocaine hydrochloride | Hospital only | ||||
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
Solution for injection | |||||
Lidocaine hydrochloride (Non-proprietary) | Hospital only | ||||
metoprolol tartrate | Joint formulary choice | ||||
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
Solution for injection | |||||
Betaloc (Recordati Pharmaceuticals Ltd) | Hospital only | ||||
mexiletine | Not approved for prescribing |
NICE TA748 |
|||
nadolol | Not approved for prescribing | ||||
propafenone hydrochloride | Hospital only | ||||
propranolol hydrochloride | Specialist knowledge/initiation | ||||
Modified-release capsule | |||||
Bedranol SR (Almus Pharmaceuticals Ltd, Sandoz Ltd) | Specialist knowledge/initiation | ||||
Beta-Prograne (Accord-UK Ltd, Tillomed Laboratories Ltd) | Specialist knowledge/initiation | ||||
Half Beta-Prograne (Accord-UK Ltd, Teva UK Ltd, Tillomed Laboratories Ltd) | Specialist knowledge/initiation | ||||
Oral solution | |||||
Propranolol hydrochloride (Non-proprietary) | Specialist knowledge/initiation | ||||
sotalol hydrochloride | Specialist knowledge/initiation | ||||
verapamil hydrochloride | Specialist knowledge/initiation | ||||
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
Verapamil for cluster headaches
Oral verapamil for cluster headaches should be prescribed under the explicit direction of a specialist only. |
|||||
Modified-release tablet | |||||
Half Securon (Viatris UK Healthcare Ltd) | Specialist knowledge/initiation | ||||
Verapamil for cluster headaches
Oral verapamil for cluster headaches should be prescribed under the explicit direction of a specialist only. |
|||||
Securon SR (Viatris UK Healthcare Ltd) | Specialist knowledge/initiation | ||||
Verapamil for cluster headaches
Oral verapamil for cluster headaches should be prescribed under the explicit direction of a specialist only. |
|||||
Vera-Til SR (Accord-UK Ltd, Tillomed Laboratories Ltd) | Specialist knowledge/initiation | ||||
Verapamil for cluster headaches
Oral verapamil for cluster headaches should be prescribed under the explicit direction of a specialist only. |
|||||
Verapress MR (Dexcel-Pharma Ltd) | Specialist knowledge/initiation | ||||
Verapamil for cluster headaches
Oral verapamil for cluster headaches should be prescribed under the explicit direction of a specialist only. |
|||||
Oral solution | |||||
Verapamil hydrochloride (Non-proprietary) | Specialist knowledge/initiation | ||||
Verapamil for cluster headaches
Oral verapamil for cluster headaches should be prescribed under the explicit direction of a specialist only. |
|||||
Solution for injection | |||||
Securon (Viatris UK Healthcare Ltd) | Hospital only | ||||
vernakalant | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
Solution for infusion | |||||
Brinavess (Correvio UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Cardiovascular system / Hypertension | |||||
acebutolol | Not approved for prescribing | ||||
aliskiren | Not approved for prescribing | ||||
amiloride hydrochloride | Joint formulary choice | ||||
Oral solution | |||||
Amiloride hydrochloride (Non-proprietary) | Joint formulary choice | ||||
amlodipine | Joint formulary choice | ||||
Oral solution | |||||
Amlodipine (Non-proprietary) | Not approved for prescribing | ||||
amlodipine with valsartan | Not approved for prescribing | ||||
atenolol | Joint formulary choice | ||||
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
Oral solution | |||||
Atenolol (Non-proprietary) | Joint formulary choice | ||||
Solution for injection | |||||
Tenormin (Atnahs Pharma UK Ltd) | Hospital only | ||||
azilsartan medoxomil | Not approved for prescribing | ||||
bendroflumethiazide | Joint formulary choice | ||||
bisoprolol fumarate | Specialist knowledge/initiation | ||||
candesartan cilexetil | Joint formulary choice | ||||
captopril | Not approved for prescribing | ||||
Oral solution | |||||
Captopril (Non-proprietary) | Not approved for prescribing | ||||
carvedilol | Specialist knowledge/initiation | ||||
celiprolol hydrochloride | Not approved for prescribing | ||||
chlortalidone | Joint formulary choice | ||||
clonidine hydrochloride | Specialist knowledge/initiation | ||||
Clonidine for the management of ADHD is hospital only
Clonidine for the management of ADHD should only be prescribed in secondary care. |
|||||
co-amilozide | Not approved for prescribing | ||||
co-tenidone | Not approved for prescribing | ||||
diltiazem hydrochloride | Joint formulary choice | ||||
Modified-release tablet | |||||
Diltiazem hydrochloride (Non-proprietary) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Retalzem (Kent Pharma (UK) Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Tildiem (Sanofi) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Tildiem Retard (Sanofi) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Modified-release capsule | |||||
Adizem-SR (Napp Pharmaceuticals Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Adizem-XL (Napp Pharmaceuticals Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Angitil SR (Ethypharm UK Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Angitil XL (Ethypharm UK Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Slozem (Zentiva Pharma UK Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Tildiem LA (Sanofi) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Viazem XL (Thornton & Ross Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Zemtard XL (Galen Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
doxazosin | Joint formulary choice | ||||
Modified-release tablet | |||||
Cardura XL (Viatris UK Healthcare Ltd) | Not approved for prescribing | ||||
Doxadura XL (Dexcel-Pharma Ltd) | Not approved for prescribing | ||||
Larbex XL (Teva UK Ltd) | Not approved for prescribing | ||||
Raporsin XL (Accord-UK Ltd) | Not approved for prescribing | ||||
enalapril maleate | Joint formulary choice | ||||
enalapril with hydrochlorothiazide | Not approved for prescribing | ||||
eprosartan | Not approved for prescribing | ||||
esmolol hydrochloride | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Solution for injection | |||||
Esmolol hydrochloride (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Brevibloc (Baxter Healthcare Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Solution for infusion | |||||
Brevibloc (Baxter Healthcare Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
felodipine | Not approved for prescribing | ||||
Modified-release tablet | |||||
Cardioplen XL (Chiesi Ltd) | Not approved for prescribing | ||||
Felendil XL (Teva UK Ltd) | Not approved for prescribing | ||||
Parmid XL (Sandoz Ltd) | Not approved for prescribing | ||||
Vascalpha (Accord-UK Ltd) | Not approved for prescribing | ||||
fosinopril sodium | Not approved for prescribing | ||||
furosemide | Joint formulary choice | ||||
Oral solution | |||||
Furosemide (Non-proprietary) | Joint formulary choice | ||||
Frusol (Rosemont Pharmaceuticals Ltd) | Joint formulary choice | ||||
Solution for injection | |||||
Furosemide (Non-proprietary) | Hospital only | ||||
hydralazine hydrochloride | Specialist knowledge/initiation | ||||
hydrochlorothiazide | Not approved for prescribing | ||||
imidapril hydrochloride | Not approved for prescribing | ||||
indapamide | Joint formulary choice | ||||
Modified-release tablet | |||||
Alkapamid XL (HBS Healthcare Ltd) | Joint formulary choice | ||||
Cardide SR (Teva UK Ltd) | Joint formulary choice | ||||
Natrilix SR (Servier Laboratories Ltd) | Joint formulary choice | ||||
indoramin | Not approved for prescribing | ||||
irbesartan | Specialist knowledge/initiation | ||||
irbesartan with hydrochlorothiazide | Not approved for prescribing | ||||
labetalol hydrochloride | Joint formulary choice | ||||
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
Solution for injection | |||||
Labetalol hydrochloride (Non-proprietary) | Hospital only | ||||
lacidipine | Not approved for prescribing | ||||
lercanidipine hydrochloride | Not approved for prescribing | ||||
lisinopril | Joint formulary choice | ||||
Oral solution | |||||
Lisinopril (Non-proprietary) | Joint formulary choice | ||||
lisinopril with hydrochlorothiazide | Not approved for prescribing | ||||
losartan potassium | Joint formulary choice | ||||
losartan with hydrochlorothiazide | Not approved for prescribing | ||||
methyldopa | Specialist knowledge/initiation | ||||
metolazone | Specialist knowledge/initiation | ||||
metoprolol tartrate | Joint formulary choice | ||||
Solution for injection | |||||
Betaloc (Recordati Pharmaceuticals Ltd) | Hospital only | ||||
minoxidil | Specialist knowledge/initiation | ||||
moxonidine | Specialist knowledge/initiation | ||||
nadolol | Not approved for prescribing | ||||
nebivolol | Not approved for prescribing | ||||
nicardipine hydrochloride | Not approved for prescribing | ||||
Solution for infusion | |||||
Nicardipine hydrochloride (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
nifedipine | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Modified-release tablet | |||||
Adalat LA (Bayer Plc) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Adanif XL (Advanz Pharma) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Adipine MR (Chiesi Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Adipine XL (Chiesi Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Fortipine LA (Advanz Pharma) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Nifedipress MR (Dexcel-Pharma Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Tensipine MR (Genus Pharmaceuticals Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Valni Retard (Tillomed Laboratories Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Valni XL (Zentiva Pharma UK Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Modified-release capsule | |||||
Coracten SR (Teofarma S.r.l.) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Coracten XL (Teofarma S.r.l.) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Oral drops | |||||
Nifedipine (Non-proprietary) | Not approved for prescribing | ||||
olmesartan medoxomil | Not approved for prescribing | ||||
olmesartan with amlodipine | Not approved for prescribing | ||||
olmesartan with amlodipine and hydrochlorothiazide | Specialist knowledge/initiation | ||||
Oral tablet | |||||
Sevikar HCT (Daiichi Sankyo UK Ltd) | Specialist knowledge/initiation | ||||
olmesartan with hydrochlorothiazide | Not approved for prescribing | ||||
perindopril arginine | Not approved for prescribing | ||||
perindopril arginine with indapamide | Not approved for prescribing | ||||
perindopril erbumine | Joint formulary choice | ||||
pindolol | Not approved for prescribing | ||||
prazosin | Not approved for prescribing | ||||
propranolol hydrochloride | Specialist knowledge/initiation | ||||
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
Modified-release capsule | |||||
Bedranol SR (Almus Pharmaceuticals Ltd, Sandoz Ltd) | Specialist knowledge/initiation | ||||
Beta-Prograne (Accord-UK Ltd, Tillomed Laboratories Ltd) | Specialist knowledge/initiation | ||||
Half Beta-Prograne (Accord-UK Ltd, Teva UK Ltd, Tillomed Laboratories Ltd) | Specialist knowledge/initiation | ||||
Oral solution | |||||
Propranolol hydrochloride (Non-proprietary) | Specialist knowledge/initiation | ||||
quinapril | Not approved for prescribing | ||||
quinapril with hydrochlorothiazide | Not approved for prescribing | ||||
ramipril | Joint formulary choice | ||||
Oral solution | |||||
Ramipril (Non-proprietary) | Joint formulary choice | ||||
ramipril with felodipine | Not approved for prescribing | ||||
spironolactone | Specialist knowledge/initiation | ||||
telmisartan | Not approved for prescribing | ||||
telmisartan with hydrochlorothiazide | Not approved for prescribing | ||||
terazosin | Not approved for prescribing | ||||
Form unstated | |||||
Hytrin (Advanz Pharma) | Not approved for prescribing | ||||
timolol maleate | Not approved for prescribing | ||||
timolol with bendroflumethiazide | Not approved for prescribing | ||||
torasemide | Not approved for prescribing | ||||
trandolapril | Not approved for prescribing | ||||
triamterene with chlortalidone | Not approved for prescribing | ||||
valsartan | Joint formulary choice | ||||
Oral solution | |||||
Diovan (Novartis Pharmaceuticals UK Ltd) | Joint formulary choice | ||||
valsartan with hydrochlorothiazide | Not approved for prescribing | ||||
verapamil hydrochloride | Specialist knowledge/initiation | ||||
Modified-release tablet | |||||
Half Securon (Viatris UK Healthcare Ltd) | Specialist knowledge/initiation | ||||
Securon SR (Viatris UK Healthcare Ltd) | Specialist knowledge/initiation | ||||
Verapamil for cluster headaches
Oral verapamil for cluster headaches should be prescribed under the explicit direction of a specialist only. |
|||||
Vera-Til SR (Accord-UK Ltd, Tillomed Laboratories Ltd) | Specialist knowledge/initiation | ||||
Verapress MR (Dexcel-Pharma Ltd) | Specialist knowledge/initiation | ||||
Oral solution | |||||
Verapamil hydrochloride (Non-proprietary) | Specialist knowledge/initiation | ||||
Solution for injection | |||||
Securon (Viatris UK Healthcare Ltd) | Hospital only | ||||
xipamide | Not approved for prescribing | ||||
Cardiovascular system / Portal hypertension | |||||
propranolol hydrochloride | Specialist knowledge/initiation | ||||
Modified-release capsule | |||||
Bedranol SR (Almus Pharmaceuticals Ltd, Sandoz Ltd) | Specialist knowledge/initiation | ||||
Beta-Prograne (Accord-UK Ltd, Tillomed Laboratories Ltd) | Specialist knowledge/initiation | ||||
Half Beta-Prograne (Accord-UK Ltd, Teva UK Ltd, Tillomed Laboratories Ltd) | Specialist knowledge/initiation | ||||
Oral solution | |||||
Propranolol hydrochloride (Non-proprietary) | Specialist knowledge/initiation | ||||
Cardiovascular system / Pulmonary hypertension | |||||
ambrisentan | Hospital only | ||||
bosentan | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
epoprostenol | Hospital only | ||||
Powder and solvent for solution for infusion | |||||
Flolan (GlaxoSmithKline UK Ltd) | Hospital only | ||||
iloprost | Hospital only | ||||
macitentan | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
riociguat | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
selexipag | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
sildenafil | Hospital only | ||||
Oral suspension | |||||
Revatio (Viatris UK Healthcare Ltd) | Hospital only | ||||
Solution for injection | |||||
Revatio (Viatris UK Healthcare Ltd) | Hospital only | ||||
tadalafil | Hospital only | ||||
Cardiovascular system / Hypertension associated with phaeochromocytoma | |||||
phenoxybenzamine hydrochloride | Not approved for prescribing | ||||
propranolol hydrochloride | Specialist knowledge/initiation | ||||
Modified-release capsule | |||||
Bedranol SR (Almus Pharmaceuticals Ltd, Sandoz Ltd) | Specialist knowledge/initiation | ||||
Beta-Prograne (Accord-UK Ltd, Tillomed Laboratories Ltd) | Specialist knowledge/initiation | ||||
Half Beta-Prograne (Accord-UK Ltd, Teva UK Ltd, Tillomed Laboratories Ltd) | Specialist knowledge/initiation | ||||
Oral solution | |||||
Propranolol hydrochloride (Non-proprietary) | Specialist knowledge/initiation | ||||
Cardiovascular system / Hypertensive crises | |||||
hydralazine hydrochloride | Specialist knowledge/initiation | ||||
Powder for solution for injection | |||||
Hydralazine hydrochloride (Non-proprietary) | Hospital only | ||||
labetalol hydrochloride | Hospital only | ||||
Solution for injection | |||||
Labetalol hydrochloride (Non-proprietary) | Hospital only | ||||
sodium nitroprusside | Hospital only | ||||
Powder and solvent for solution for infusion | |||||
Sodium nitroprusside (Non-proprietary) | Hospital only | ||||
Cardiovascular system / Hypotension and shock | |||||
angiotensin II | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
Solution for infusion | |||||
Giapreza (PAION Deutschland GmbH) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
dobutamine | Hospital only | ||||
Solution for infusion | |||||
Dobutamine (Non-proprietary) | Hospital only | ||||
dopamine hydrochloride | Hospital only | ||||
Solution for infusion | |||||
Dopamine hydrochloride (Non-proprietary) | Hospital only | ||||
ephedrine hydrochloride | Hospital only | ||||
Solution for injection | |||||
Ephedrine hydrochloride (Non-proprietary) | Hospital only | ||||
metaraminol | Hospital only | ||||
Solution for injection | |||||
Metaraminol (Non-proprietary) | Hospital only | ||||
midodrine hydrochloride | Specialist knowledge/initiation | ||||
noradrenaline/norepinephrine | Hospital only | ||||
Solution for infusion | |||||
Noradrenaline/norepinephrine (Non-proprietary) | Hospital only | ||||
phenylephrine hydrochloride | Hospital only | ||||
Solution for injection | |||||
Phenylephrine hydrochloride (Non-proprietary) | Hospital only | ||||
sodium nitroprusside | Hospital only | ||||
Powder and solvent for solution for infusion | |||||
Sodium nitroprusside (Non-proprietary) | Hospital only | ||||
Cardiovascular system / Vascular disease | |||||
cilostazol | Not approved for prescribing |
NICE TA223 |
|||
inositol nicotinate | Not approved for prescribing |
NICE TA223 |
|||
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
naftidrofuryl oxalate | Specialist knowledge/initiation |
NICE TA223 |
|||
nifedipine | Joint formulary choice | ||||
Oral drops | |||||
Nifedipine (Non-proprietary) | Not approved for prescribing | ||||
oxerutins | Not approved for prescribing | ||||
pentoxifylline | Not approved for prescribing |
NICE TA223 |
|||
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
Modified-release tablet | |||||
Trental (Neuraxpharm UK Ltd) | Not approved for prescribing | ||||
prazosin | Not approved for prescribing | ||||
Cardiovascular system / Vein malformations | |||||
sodium tetradecyl sulfate | Not approved for prescribing | ||||
Solution for injection | |||||
Fibro-Vein (STD Pharmaceutical Products Ltd) | Not approved for prescribing | ||||
Cardiovascular system / Cardiomyopathy | |||||
mavacamten | Non-formulary at HHFT and not suitable for primary care prescribing |
NICE TA913 |
|||
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
Oral capsule | |||||
Camzyos (Bristol-Myers Squibb Pharmaceuticals Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Cardiovascular system / Cardiac diagnostic procedures and surgeries | |||||
dobutamine | Hospital only | ||||
Solution for infusion | |||||
Dobutamine (Non-proprietary) | Hospital only | ||||
Cardiovascular system / Blocked catheters and lines | |||||
epoprostenol | Hospital only | ||||
Powder and solvent for solution for infusion | |||||
Flolan (GlaxoSmithKline UK Ltd) | Hospital only | ||||
heparin (unfractionated) | Hospital only | ||||
Solution for injection | |||||
Heparin (unfractionated) (Non-proprietary) | Hospital only | ||||
Infusion | |||||
Heparin (unfractionated) (Non-proprietary) | Hospital only | ||||
Form unstated | |||||
Heparin (unfractionated) (Non-proprietary) | Hospital only | ||||
urokinase | Hospital only | ||||
Powder for solution for injection | |||||
Syner-KINASE (Syner-Med (Pharmaceutical Products) Ltd) | Hospital only | ||||
Cardiovascular system / Thromboembolism | |||||
acenocoumarol | Specialist knowledge/initiation | ||||
alteplase | Hospital only |
NICE TA264 |
|||
Powder and solvent for solution for injection | |||||
Actilyse (Boehringer Ingelheim Ltd) | Hospital only | ||||
Powder and solvent for solution for infusion | |||||
Actilyse (Boehringer Ingelheim Ltd) | Hospital only | ||||
andexanet alfa | Hospital only |
NICE TA697 |
|||
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
Powder for solution for infusion | |||||
Ondexxya (AstraZeneca UK Ltd) | Hospital only | ||||
apixaban | Specialist knowledge/initiation |
NICE TA245 NICE TA275 NICE TA341 |
|||
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
Change of formulary status from Amber (shared care) to Amber (specialist knowledge/initiation)
February 2020 - the Joint Prescribing Group (JPG) agreed to approve the change of formulary status for apixaban, dabigatran, edoxaban and rivaroxaban from Amber (shared care) to Amber (specialist knowledge/initiation) as these drugs are now commonly initiated in primary care. 'Transfer of care' documents are still available to provide prescribing and monitoring guidance for these drugs. |
|||||
argatroban monohydrate | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Solution for infusion | |||||
Argatroban monohydrate (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Exembol (Mitsubishi Tanabe Pharma Europe Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
aspirin | Joint formulary choice | ||||
Gastro-resistant tablet | |||||
Aspirin (Non-proprietary) | Joint formulary choice | ||||
bivalirudin | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
Powder for solution for infusion | |||||
Bivalirudin (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
clopidogrel | Joint formulary choice |
NICE TA210 |
|||
dabigatran etexilate | Specialist knowledge/initiation |
NICE TA157 NICE TA249 NICE TA327 |
|||
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
Change of formulary status from Amber (shared care) to Amber (specialist knowledge/initiation)
February 2020 - the Joint Prescribing Group (JPG) agreed to approve the change of formulary status for apixaban, dabigatran, edoxaban and rivaroxaban from Amber (shared care) to Amber (specialist knowledge/initiation) as these drugs are now commonly initiated in primary care. 'Transfer of care' documents are still available to provide prescribing and monitoring guidance for these drugs. |
|||||
dalteparin sodium | Hospital only | ||||
Thromboprophylaxis
June 2020 - the JPG agreed to approve the addition of dalteparin to the joint formulary. Dalteparin should only be used in line with HUHFT policy on Thromboprophylaxis and treatment of VTE complications in COVID-19 infection. |
|||||
Solution for injection | |||||
Fragmin (Pfizer Ltd) | Not approved for prescribing | ||||
danaparoid sodium | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Solution for injection | |||||
Danaparoid sodium (Non-proprietary) | Not approved for prescribing | ||||
dipyridamole | Joint formulary choice |
NICE TA210 |
|||
Modified-release capsule | |||||
Attia (Dr Reddy's Laboratories (UK) Ltd) | Joint formulary choice | ||||
Oral suspension | |||||
Dipyridamole (Non-proprietary) | Joint formulary choice | ||||
edoxaban | Specialist knowledge/initiation |
NICE TA354 NICE TA355 |
|||
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
Change of formulary status from Amber (shared care) to Amber (specialist knowledge/initiation)
February 2020 - the Joint Prescribing Group (JPG) agreed to approve the change of formulary status for apixaban, dabigatran, edoxaban and rivaroxaban from Amber (shared care) to Amber (specialist knowledge/initiation) as these drugs are now commonly initiated in primary care. 'Transfer of care' documents are still available to provide prescribing and monitoring guidance for these drugs. |
|||||
enoxaparin sodium | Shared care guideline | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
Solution for injection | |||||
Clexane (Sanofi) | Shared care guideline | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
Inhixa (Techdow Pharma England Ltd) | Shared care guideline | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
A formal Shared Care Guideline (SCG) may be available
Happy to prescribe If you are asked to continue treatment for a specific condition for which a shared care guideline is available and you are happy to prescribe in accordance with the guidance then take over the agreed responsibilities, including prescribing. Please obtain a copy of the SCG from secondary care or via the link below. Unhappy to prescribe If sufficient information has not been provided and if you do not feel happy to continue to prescribe then it is advisable to refer the patient back to the specialist clinic. Please complete an inappropriate request communication form and send this as soon as possible to the contact provided in the form. |
|||||
fondaparinux sodium | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Solution for injection | |||||
Fondaparinux sodium (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Arixtra (Viatris UK Healthcare Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
heparin (unfractionated) | Hospital only | ||||
Solution for injection | |||||
Heparin (unfractionated) (Non-proprietary) | Hospital only | ||||
Infusion | |||||
Heparin (unfractionated) (Non-proprietary) | Hospital only | ||||
Form unstated | |||||
Heparin (unfractionated) (Non-proprietary) | Hospital only | ||||
idarucizumab | Hospital only | ||||
Solution for infusion | |||||
Praxbind (Boehringer Ingelheim Ltd) | Hospital only | ||||
phenindione | Specialist knowledge/initiation | ||||
prasugrel | Specialist knowledge/initiation |
NICE TA317 |
|||
rivaroxaban | Specialist knowledge/initiation |
NICE TA170 NICE TA256 NICE TA261 NICE TA287 NICE TA335 NICE TA607 |
|||
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
Change of formulary status from Amber (shared care) to Amber (specialist knowledge/initiation)
February 2020 - the Joint Prescribing Group (JPG) agreed to approve the change of formulary status for apixaban, dabigatran, edoxaban and rivaroxaban from Amber (shared care) to Amber (specialist knowledge/initiation) as these drugs are now commonly initiated in primary care. 'Transfer of care' documents are still available to provide prescribing and monitoring guidance for these drugs. |
|||||
streptokinase | Hospital only | ||||
tinzaparin sodium | Hospital only | ||||
Solution for injection | |||||
Tinzaparin sodium (Non-proprietary) | Hospital only | ||||
urokinase | Hospital only | ||||
Powder for solution for injection | |||||
Syner-KINASE (Syner-Med (Pharmaceutical Products) Ltd) | Hospital only | ||||
warfarin sodium | Specialist knowledge/initiation | ||||
Oral suspension | |||||
Warfarin sodium (Non-proprietary) | Specialist knowledge/initiation | ||||
Cardiovascular system / Oedema | |||||
amiloride hydrochloride | Joint formulary choice | ||||
Oral solution | |||||
Amiloride hydrochloride (Non-proprietary) | Joint formulary choice | ||||
amiloride with bumetanide | Not approved for prescribing | ||||
bumetanide | Joint formulary choice | ||||
Oral solution | |||||
Bumetanide (Non-proprietary) | Joint formulary choice | ||||
chlortalidone | Joint formulary choice | ||||
co-amilofruse | Not approved for prescribing | ||||
diamorphine hydrochloride | Hospital only | ||||
Powder for solution for injection | |||||
Diamorphine hydrochloride (Non-proprietary) | Hospital only | ||||
furosemide | Joint formulary choice | ||||
Oral solution | |||||
Furosemide (Non-proprietary) | Joint formulary choice | ||||
Frusol (Rosemont Pharmaceuticals Ltd) | Joint formulary choice | ||||
Solution for injection | |||||
Furosemide (Non-proprietary) | Hospital only | ||||
furosemide with triamterene | Not approved for prescribing | ||||
mannitol | Hospital only |
NICE TA266 |
|||
Infusion | |||||
Mannitol (Non-proprietary) | Hospital only | ||||
Inhalation powder | |||||
Mannitol (Non-proprietary) | Hospital only | ||||
Bronchitol (Chiesi Ltd) | Hospital only | ||||
metolazone | Specialist knowledge/initiation | ||||
spironolactone with furosemide | Not approved for prescribing | ||||
torasemide | Not approved for prescribing | ||||
triamterene | Not approved for prescribing | ||||
triamterene with chlortalidone | Not approved for prescribing | ||||
xipamide | Not approved for prescribing | ||||
Cardiovascular system / Ascites | |||||
chlortalidone | Joint formulary choice | ||||
co-amilozide | Not approved for prescribing | ||||
spironolactone | Specialist knowledge/initiation | ||||
Cardiovascular system / Hyperlipidaemia | |||||
acipimox | Not approved for prescribing | ||||
alirocumab | Hospital only |
NICE TA393 |
|||
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
Solution for injection | |||||
Praluent (Sanofi) | Hospital only | ||||
atorvastatin | Joint formulary choice | ||||
Chewable tablet | |||||
Lipitor (Viatris UK Healthcare Ltd) | Not approved for prescribing | ||||
bempedoic acid | Specialist knowledge/initiation |
NICE TA694 |
|||
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
bempedoic acid with ezetimibe | Specialist knowledge/initiation |
NICE TA694 |
|||
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
bezafibrate | Joint formulary choice | ||||
Modified-release tablet | |||||
Bezalip Mono (Teva UK Ltd) | Joint formulary choice | ||||
ciprofibrate | Not approved for prescribing | ||||
colesevelam hydrochloride | Not approved for prescribing | ||||
colestipol hydrochloride | Not approved for prescribing | ||||
colestyramine | Not approved for prescribing | ||||
evolocumab | Hospital only |
NICE TA394 |
|||
Solution for injection | |||||
Repatha SureClick (Amgen Ltd) | Hospital only | ||||
ezetimibe | Joint formulary choice |
NICE TA385 |
|||
fenofibrate | Not approved for prescribing | ||||
fluvastatin | Not approved for prescribing | ||||
gemfibrozil | Not approved for prescribing | ||||
icosapent ethyl | Joint formulary choice |
NICE TA805 |
|||
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
Oral capsule | |||||
Vazkepa (Amarin Pharmaceuticals Ireland Ltd) | Joint formulary choice | ||||
inclisiran | Joint formulary choice |
NICE TA733 |
|||
Where positive NICE Technology Appraisal(s) apply to this medicine
This medicine is recommended for use at Homerton Healthcare NHS Foundation Trust provided it is used specifically in accordance with the relevant current NICE Technology Appraisal(s). |
|||||
Inclisiran prescribing in primary care
Please note the North East London primary care prescribing pathway, including training resources for primary care prescribers are currently under development. Primary care prescribers are advised to wait for the prescribing pathway and training to be finalised prior to initiating inclisiran in line with NICE TA733 |
|||||
Solution for injection | |||||
Leqvio (Novartis Pharmaceuticals UK Ltd) | Joint formulary choice | ||||
Inclisiran prescribing in primary care
Please note the North East London primary care prescribing pathway, including training resources for primary care prescribers are currently under development. Primary care prescribers are advised to wait for the prescribing pathway and training to be finalised prior to initiating inclisiran in line with NICE TA733 |
|||||
lomitapide | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
nicotinic acid | Not approved for prescribing | ||||
omega-3-acid ethyl esters | Not approved for prescribing | ||||
pravastatin sodium | Joint formulary choice | ||||
rosuvastatin | Not approved for prescribing | ||||
simvastatin | Joint formulary choice | ||||
Oral suspension | |||||
Simvastatin (Non-proprietary) | Joint formulary choice | ||||
simvastatin with ezetimibe | Not approved for prescribing | ||||
Cardiovascular system / Bleeding disorders | |||||
emicizumab | Not approved for prescribing | ||||
Solution for injection | |||||
Hemlibra (Roche Products Ltd) | Not approved for prescribing | ||||
tranexamic acid | Joint formulary choice | ||||
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
Solution for injection | |||||
Tranexamic acid (Non-proprietary) | Hospital only | ||||
Cyklokapron (Pfizer Ltd) | Hospital only | ||||
Cardiovascular system / Coagulation factor deficiencies | |||||
dried prothrombin complex | Not approved for prescribing | ||||
factor IX [Specialist drug] | Not approved for prescribing | ||||
Powder and solvent for solution for injection | |||||
Haemonine (Grifols UK Ltd) | Not approved for prescribing | ||||
Replenine-VF (Bio Products Laboratory Ltd) | Not approved for prescribing | ||||
Powder and solvent for solution for infusion | |||||
BeneFIX (Pfizer Ltd) | Not approved for prescribing | ||||
factor VIII fraction, dried [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Powder and solvent for solution for injection | |||||
Factor VIII fraction, dried (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Advate (Takeda UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Elocta (Swedish Orphan Biovitrum Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Haemoctin (Grifols UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Nuwiq (Octapharma Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Octanate LV (Octapharma Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
ReFacto (Pfizer Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Voncento (CSL Behring UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Powder and solvent for solution for infusion | |||||
Advate (Takeda UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Wilate 1000 (Octapharma Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Wilate 500 (Octapharma Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
factor VIII inhibitor bypassing fraction [Specialist drug] | Not approved for prescribing | ||||
Powder and solvent for solution for infusion | |||||
FEIBA Imuno (Takeda UK Ltd) | Not approved for prescribing | ||||
factor VIIa (recombinant) | Hospital only | ||||
Powder and solvent for solution for injection | |||||
NovoSeven (Novo Nordisk Ltd) | Hospital only | ||||
factor XIII fraction, dried [Specialist drug] | Not approved for prescribing | ||||
Powder and solvent for solution for injection | |||||
Fibrogammin P (CSL Behring UK Ltd) | Not approved for prescribing | ||||
fibrinogen, dried [Specialist drug] | Not approved for prescribing | ||||
fresh frozen plasma | Hospital only | ||||
protein C concentrate [Specialist drug] | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Powder and solvent for solution for injection | |||||
Ceprotin (Takeda UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Cardiovascular system / Subarachnoid haemorrhage | |||||
nimodipine | Hospital only | ||||
Solution for infusion | |||||
Nimotop (Bayer Plc) | Hospital only | ||||
Cardiovascular system / Heart failure | |||||
bendroflumethiazide | Not approved for prescribing | ||||
bisoprolol fumarate | Specialist knowledge/initiation | ||||
candesartan cilexetil | Joint formulary choice | ||||
captopril | Not approved for prescribing | ||||
Oral solution | |||||
Captopril (Non-proprietary) | Not approved for prescribing | ||||
chlortalidone | Joint formulary choice | ||||
co-amilozide | Not approved for prescribing | ||||
co-flumactone | Not approved for prescribing | ||||
dapagliflozin | Specialist knowledge/initiation |
NICE TA288 NICE TA390 NICE TA418 NICE TA679 NICE TA902 NICE TA775 |
|||
Dapagliflozin and empagliflozin for heart failure
Dapagliflozin and empagliflozin for heart failure should only be initiated by or on recommendation of a specialist. |
|||||
Oral tablet | |||||
Forxiga (AstraZeneca UK Ltd) | Specialist knowledge/initiation | ||||
digoxin | Specialist knowledge/initiation | ||||
Solution for injection | |||||
Digoxin (Non-proprietary) | Hospital only | ||||
empagliflozin | Specialist knowledge/initiation |
NICE TA390 NICE TA336 NICE TA773 NICE TA929 NICE TA942 |
|||
Dapagliflozin and empagliflozin for heart failure
Dapagliflozin and empagliflozin for heart failure should only be initiated by or on recommendation of a specialist. |
|||||
Oral tablet | |||||
Jardiance (Boehringer Ingelheim Ltd) | Specialist knowledge/initiation | ||||
enalapril maleate | Joint formulary choice | ||||
enoximone | Hospital only | ||||
Solution for injection | |||||
Perfan (Macure Pharma UK Ltd) | Hospital only | ||||
eplerenone | Specialist knowledge/initiation | ||||
fosinopril sodium | Not approved for prescribing | ||||
glyceryl trinitrate | Hospital only | ||||
hydralazine hydrochloride | Specialist knowledge/initiation | ||||
isosorbide dinitrate | Not approved for prescribing | ||||
Injection/infusion formulations
The injection/infusion formulation of this medicine is not recommended for prescribing in primary care (i.e. hospital only prescribing). |
|||||
Modified-release tablet | |||||
Isoket Retard (Forum Health Products Ltd) | Not approved for prescribing | ||||
Solution for injection | |||||
Isosorbide dinitrate (Non-proprietary) | Hospital only | ||||
Isoket (Forum Health Products Ltd) | Hospital only | ||||
Solution for infusion | |||||
Isosorbide dinitrate (Non-proprietary) | Hospital only | ||||
isosorbide mononitrate | Joint formulary choice | ||||
Modified-release tablet | |||||
Isotard XL (Evolan Pharma AB) | Joint formulary choice | ||||
Modisal XL (Ennogen Pharma Ltd) | Joint formulary choice | ||||
Relosorb XL (Relonchem Ltd) | Joint formulary choice | ||||
Xismox XL (Genus Pharmaceuticals Ltd) | Joint formulary choice | ||||
Modified-release capsule | |||||
Elantan LA (Forum Health Products Ltd) | Joint formulary choice | ||||
Isodur XL (Galen Ltd) | Joint formulary choice | ||||
Monomax SR (Martindale Pharmaceuticals Ltd) | Joint formulary choice | ||||
ivabradine | Specialist knowledge/initiation |
NICE TA267 |
|||
lisinopril | Joint formulary choice | ||||
Oral solution | |||||
Lisinopril (Non-proprietary) | Joint formulary choice | ||||
losartan potassium | Joint formulary choice | ||||
milrinone | Hospital only | ||||
Solution for infusion | |||||
Milrinone (Non-proprietary) | Hospital only | ||||
nebivolol | Not approved for prescribing | ||||
perindopril arginine | Not approved for prescribing | ||||
perindopril erbumine | Joint formulary choice | ||||
prazosin | Not approved for prescribing | ||||
quinapril | Not approved for prescribing | ||||
ramipril | Joint formulary choice | ||||
Oral solution | |||||
Ramipril (Non-proprietary) | Joint formulary choice | ||||
sacubitril with valsartan | Specialist knowledge/initiation |
NICE TA388 |
|||
sodium nitroprusside | Hospital only | ||||
Powder and solvent for solution for infusion | |||||
Sodium nitroprusside (Non-proprietary) | Hospital only | ||||
spironolactone | Specialist knowledge/initiation | ||||
valsartan | Joint formulary choice | ||||
Oral solution | |||||
Diovan (Novartis Pharmaceuticals UK Ltd) | Joint formulary choice | ||||
vericiguat | Not approved for prescribing | ||||
Where negative or terminated NICE Technology Appraisal(s) apply to this medicine
This medicine is not recommended for use for the indication(s) specified in the relevant NICE Technology Appraisal(s) as currently NICE cannot recommend its use. |
|||||
Cardiovascular system / Myocardial ischaemia | |||||
acebutolol | Not approved for prescribing | ||||
amlodipine | Joint formulary choice | ||||
Oral solution | |||||
Amlodipine (Non-proprietary) | Not approved for prescribing | ||||
aspirin | Joint formulary choice | ||||
Gastro-resistant tablet | |||||
Aspirin (Non-proprietary) | Joint formulary choice | ||||
atenolol | Joint formulary choice | ||||
Oral solution | |||||
Atenolol (Non-proprietary) | Joint formulary choice | ||||
Solution for injection | |||||
Tenormin (Atnahs Pharma UK Ltd) | Hospital only | ||||
bisoprolol fumarate | Specialist knowledge/initiation | ||||
bivalirudin | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Where positive NICE Technology Appraisal(s) apply to this medicine but Homerton Healthcare NHS Foundation Trust does not provide the service
This medicine is not recommended for use at Homerton Healthcare NHS Foundation Trust as the trust does not provide this specialist service. Note that this medicine may be prescribed by other provider trusts that are accredited to provide this specialist service. |
|||||
Powder for solution for infusion | |||||
Bivalirudin (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
cangrelor | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Powder for solution for injection | |||||
Kengrexal (Chiesi Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
carvedilol | Specialist knowledge/initiation | ||||
diltiazem hydrochloride | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Modified-release tablet | |||||
Diltiazem hydrochloride (Non-proprietary) | Joint formulary choice | ||||
Retalzem (Kent Pharma (UK) Ltd) | Joint formulary choice | ||||
Tildiem (Sanofi) | Joint formulary choice | ||||
Tildiem Retard (Sanofi) | Joint formulary choice | ||||
Modified-release capsule | |||||
Adizem-SR (Napp Pharmaceuticals Ltd) | Joint formulary choice | ||||
Adizem-XL (Napp Pharmaceuticals Ltd) | Joint formulary choice | ||||
Angitil SR (Ethypharm UK Ltd) | Joint formulary choice | ||||
Brand prescribing recommended
Although generic prescribing is encouraged, there are some circumstances in which it is preferable to prescribe by brand name, these include where:
Please prescribe this product by brand. |
|||||
Angitil XL (Ethypharm UK Ltd) | Joint formulary choice | ||||
Slozem (Zentiva Pharma UK Ltd) | Joint formulary choice | ||||
Tildiem LA (Sanofi) | Joint formulary choice | ||||
Viazem XL (Thornton & Ross Ltd) | Joint formulary choice | ||||
Zemtard XL (Galen Ltd) | Joint formulary choice | ||||
eptifibatide | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Solution for injection | |||||
Eptifibatide (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Solution for infusion | |||||
Eptifibatide (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
felodipine | Not approved for prescribing | ||||
Modified-release tablet | |||||
Cardioplen XL (Chiesi Ltd) | Not approved for prescribing | ||||
Felendil XL (Teva UK Ltd) | Not approved for prescribing | ||||
Parmid XL (Sandoz Ltd) | Not approved for prescribing | ||||
Vascalpha (Accord-UK Ltd) | Not approved for prescribing | ||||
fondaparinux sodium | Hospital only | ||||
Solution for injection | |||||
Fondaparinux sodium (Non-proprietary) | Hospital only | ||||
Arixtra (Viatris UK Healthcare Ltd) | Hospital only | ||||
glyceryl trinitrate | Joint formulary choice | ||||
Sublingual tablet | |||||
Glyceryl trinitrate (Non-proprietary) | Joint formulary choice | ||||
Sublingual spray | |||||
Glyceryl trinitrate (Non-proprietary) | Joint formulary choice | ||||
Nitrolingual (Beaumont Pharma Ltd) | Joint formulary choice | ||||
Transdermal patch | |||||
Deponit (Forum Health Products Ltd) | Joint formulary choice | ||||
Minitran (Viatris UK Healthcare Ltd) | Joint formulary choice | ||||
Transiderm-Nitro (Novartis Pharmaceuticals UK Ltd) | Joint formulary choice | ||||
ivabradine | Specialist knowledge/initiation |
NICE TA267 |
|||
metoprolol tartrate | Joint formulary choice | ||||
Solution for injection | |||||
Betaloc (Recordati Pharmaceuticals Ltd) | Hospital only | ||||
nadolol | Not approved for prescribing | ||||
nicardipine hydrochloride | Not approved for prescribing | ||||
Solution for infusion | |||||
Nicardipine hydrochloride (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
nicorandil | Specialist knowledge/initiation | ||||
nifedipine | Joint formulary choice | ||||
Modified-release tablet | |||||
Adalat LA (Bayer Plc) | Joint formulary choice | ||||
Adanif XL (Advanz Pharma) | Joint formulary choice | ||||
Adipine MR (Chiesi Ltd) | Joint formulary choice | ||||
Adipine XL (Chiesi Ltd) | Joint formulary choice | ||||
Fortipine LA (Advanz Pharma) | Joint formulary choice | ||||
Nifedipress MR (Dexcel-Pharma Ltd) | Joint formulary choice | ||||
Tensipine MR (Genus Pharmaceuticals Ltd) | Joint formulary choice | ||||
Valni Retard (Tillomed Laboratories Ltd) | Joint formulary choice | ||||
Valni XL (Zentiva Pharma UK Ltd) | Joint formulary choice | ||||
Modified-release capsule | |||||
Coracten SR (Teofarma S.r.l.) | Joint formulary choice | ||||
Coracten XL (Teofarma S.r.l.) | Joint formulary choice | ||||
Oral drops | |||||
Nifedipine (Non-proprietary) | Not approved for prescribing | ||||
pindolol | Not approved for prescribing | ||||
propranolol hydrochloride | Specialist knowledge/initiation | ||||
Modified-release capsule | |||||
Bedranol SR (Almus Pharmaceuticals Ltd, Sandoz Ltd) | Specialist knowledge/initiation | ||||
Beta-Prograne (Accord-UK Ltd, Tillomed Laboratories Ltd) | Specialist knowledge/initiation | ||||
Half Beta-Prograne (Accord-UK Ltd, Teva UK Ltd, Tillomed Laboratories Ltd) | Specialist knowledge/initiation | ||||
Oral solution | |||||
Propranolol hydrochloride (Non-proprietary) | Specialist knowledge/initiation | ||||
ranolazine | Specialist knowledge/initiation | ||||
Modified-release tablet | |||||
Ranexa (A. Menarini Farmaceutica Internazionale SRL) | Specialist knowledge/initiation | ||||
timolol maleate | Not approved for prescribing | ||||
tirofiban | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Infusion | |||||
Tirofiban (Non-proprietary) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Aggrastat (Correvio UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
Solution for infusion | |||||
Aggrastat (Correvio UK Ltd) | Non-formulary at HHFT and not suitable for primary care prescribing | ||||
verapamil hydrochloride | Specialist knowledge/initiation | ||||
Modified-release tablet | |||||
Half Securon (Viatris UK Healthcare Ltd) | Specialist knowledge/initiation | ||||
Securon SR (Viatris UK Healthcare Ltd) | Specialist knowledge/initiation | ||||
Verapamil for cluster headaches
Oral verapamil for cluster headaches should be prescribed under the explicit direction of a specialist only. |
|||||
Vera-Til SR (Accord-UK Ltd, Tillomed Laboratories Ltd) | Specialist knowledge/initiation | ||||
Verapress MR (Dexcel-Pharma Ltd) | Specialist knowledge/initiation | ||||
Oral solution | |||||
Verapamil hydrochloride (Non-proprietary) | Specialist knowledge/initiation | ||||
Solution for injection | |||||
Securon (Viatris UK Healthcare Ltd) | Hospital only | ||||
Cardiovascular system / Acute coronary syndromes | |||||
alteplase | Hospital only |
NICE TA264 |
|||
Powder and solvent for solution for injection | |||||
Actilyse (Boehringer Ingelheim Ltd) | Hospital only | ||||
Powder and solvent for solution for infusion | |||||
Actilyse (Boehringer Ingelheim Ltd) | Hospital only | ||||
captopril | Not approved for prescribing | ||||
Oral solution | |||||
Captopril (Non-proprietary) | Not approved for prescribing | ||||
clopidogrel | Joint formulary choice |
NICE TA210 |
|||
dalteparin sodium | Not approved for prescribing | ||||
Solution for injection | |||||
Fragmin (Pfizer Ltd) | Not approved for prescribing | ||||
enoxaparin sodium | Hospital only | ||||
Solution for injection | |||||
Clexane (Sanofi) | Hospital only | ||||
Inhixa (Techdow Pharma England Ltd) | Hospital only | ||||
glyceryl trinitrate | Hospital only | ||||
Solution for infusion | |||||
Glyceryl trinitrate (Non-proprietary) | Hospital only | ||||
Nitronal (Beaumont Pharma Ltd) | Hospital only | ||||
heparin (unfractionated) | Hospital only | ||||
Solution for injection | |||||
Heparin (unfractionated) (Non-proprietary) | Hospital only | ||||
Infusion | |||||
Heparin (unfractionated) (Non-proprietary) | Hospital only | ||||
Form unstated | |||||
Heparin (unfractionated) (Non-proprietary) | Hospital only | ||||
isosorbide dinitrate | Not approved for prescribing | ||||
Modified-release tablet | |||||
Isoket Retard (Forum Health Products Ltd) | Not approved for prescribing | ||||
Solution for injection | |||||
Isosorbide dinitrate (Non-proprietary) | Hospital only | ||||
Isoket (Forum Health Products Ltd) | Hospital only | ||||
Solution for infusion | |||||
Isosorbide dinitrate (Non-proprietary) | Hospital only | ||||
isosorbide mononitrate | Joint formulary choice | ||||
Modified-release tablet | |||||
Isotard XL (Evolan Pharma AB) | Joint formulary choice | ||||
Modisal XL (Ennogen Pharma Ltd) | Joint formulary choice | ||||
Relosorb XL (Relonchem Ltd) | Joint formulary choice | ||||
Xismox XL (Genus Pharmaceuticals Ltd) | Joint formulary choice | ||||
Modified-release capsule | |||||
Elantan LA (Forum Health Products Ltd) | Joint formulary choice | ||||
Isodur XL (Galen Ltd) | Joint formulary choice | ||||
Monomax SR (Martindale Pharmaceuticals Ltd) | Joint formulary choice | ||||
lisinopril | Joint formulary choice | ||||
Oral solution | |||||
Lisinopril (Non-proprietary) | Joint formulary choice | ||||
perindopril arginine | Not approved for prescribing | ||||
perindopril erbumine | Joint formulary choice | ||||
prasugrel | Specialist knowledge/initiation |
NICE TA317 |
|||
ramipril | Joint formulary choice | ||||
Oral solution | |||||
Ramipril (Non-proprietary) | Joint formulary choice | ||||
streptokinase | Hospital only | ||||
tenecteplase | Hospital only | ||||
Powder and solvent for solution for injection | |||||
Metalyse (Boehringer Ingelheim Ltd) | Hospital only | ||||
ticagrelor | Specialist knowledge/initiation |
NICE TA236 NICE TA420 |
|||
trandolapril | Not approved for prescribing | ||||
valsartan | Joint formulary choice | ||||
Oral solution | |||||
Diovan (Novartis Pharmaceuticals UK Ltd) | Joint formulary choice | ||||
Cardiovascular system / Cardiac arrest | |||||
adrenaline/epinephrine | Hospital only | ||||
Solution for injection | |||||
Adrenaline/epinephrine (Non-proprietary) | Hospital only |